Table 1– Factors associated with polypharmacy at discharge
Univariate analysisMultivariate analysis
OR (95% CI)p-valueOR (95% CI)p-value
Age by decade years1.33 (1.03–1.73)0.031.02 (0.99–1.05)0.22
10% predicted FEV10.81 (0.67–0.99)0.0380.73 (0.57–0.93)0.01
Charlson index1.21 (1.01–1.44)0.030.92 (0.76–1.13)0.43
Heart failure7.52 (2.95–19.20)0.00023.94 (1.36–11.43)0.01
Coronary artery disease3.05 (1.26–7.34)0.012.26 (0.80–6.33)0.12
Hypertension3.19 (1.90–5.36)0.00011.71 (0.90–3.26)0.10
Cardiac arrhythmia3.49 (1.67–7.29)0.00090.81 (0.33–2.08)0.68
Diabetes2.30 (1.23–4.29)0.0091.81 (0.85–3.87)0.12
Osteoporosis3.37 (1.01–11.28)0.0481.39 (0.36–5.39)0.63
Polypharmacy at admission19.31 (8.94–41.68)0.000513.10 (5.67–30.28)0.0002
  • FEV1: forced expiratory volume in 1 s.